Analysen zu OMX Copenhagen PI-Werten
10:04 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
28.04.25 | Novo Nordisk Buy | UBS AG | |
25.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
22.04.25 | Novo Nordisk Buy | UBS AG | |
22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
17.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.04.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
08.04.25 | Novo Nordisk Buy | UBS AG | |
07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
07.04.25 | Novo Nordisk Buy | UBS AG | |
04.04.25 | Novo Nordisk Buy | UBS AG | |
04.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
31.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
27.03.25 | A.P. Moeller - Maersk A-S Sell | Deutsche Bank AG | |
24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
24.03.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.03.25 | Novo Nordisk Buy | UBS AG | |
17.03.25 | Novo Nordisk Buy | UBS AG | |
14.03.25 | Novo Nordisk Buy | UBS AG | |
12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.03.25 | Novo Nordisk Buy | UBS AG | |
10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
10.03.25 | Novo Nordisk Market-Perform | Bernstein Research |